Lindbrook Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $12.1K | Buy |
360
+23
| +7% | +$771 | ﹤0.01% | 1577 |
|
|
2024
Q4 | $17.2K | Sell |
337
-26
| -7% | -$1.33K | ﹤0.01% | 1366 |
|
|
2024
Q3 | $18.5K | Buy |
363
+9
| +3% | +$460 | ﹤0.01% | 1344 |
|
|
2024
Q2 | $15.9K | Buy |
354
+77
| +28% | +$3.45K | ﹤0.01% | 1380 |
|
|
2024
Q1 | $13K | Buy |
277
+244
| +739% | +$11.4K | ﹤0.01% | 1428 |
|
|
2023
Q4 | $1.17K | Sell |
33
-16
| -33% | -$569 | ﹤0.01% | 2434 |
|
|
2023
Q3 | $1.46K | Buy |
+49
| New | +$1.46K | ﹤0.01% | 2234 |
|
|
2022
Q4 | – | Sell |
-113
| Closed | -$2K | – | 2869 |
|
|
2022
Q3 | $2K | Buy |
113
+12
| +12% | +$212 | ﹤0.01% | 2024 |
|
|
2022
Q2 | $2K | Buy |
101
+67
| +197% | +$1.33K | ﹤0.01% | 1930 |
|
|
2022
Q1 | $1K | Buy |
+34
| New | +$1K | ﹤0.01% | 2194 |
|